Skip to main content
Fig. 2 | Orphanet Journal of Rare Diseases

Fig. 2

From: Awareness and agreement with neurofibromatosis care guidelines among U.S. neurofibromatosis specialists

Fig. 2

NF Clinician Agreement with Neurofibromatosis 2 and Schwannomatosis Recommendations. Stacked bar charts displaying the percentage of clinicians who “strongly agreed” (dark blue), “agreed” (orange), were “neutral” (gray), “disagreed” (yellow), or “strongly disagreed” (light blue) with each recommendation. Overlaid boxes display the percentage of clinicians who “strongly agreed” (dark blue) and “agreed” (orange) with each recommendation, rounded to the nearest percentage point. Recommendations are presented with short descriptions for reference; for fulltext and citations please refer to Table 1, where all recommendations are presented in the same rank order. NF = neurofibromatosis; MRI = magnetic resonance imaging; PTA = pure tone average; WRS = word recognition score. SMARCB1 and LZTR1 refer to gene variants known to cause schwannomatosis

Back to article page